FBInvestor
Stocks / Crinetics Pharmaceuticals In
Institutional Ownership

Crinetics Pharmaceuticals In

CUSIP 22663K107COMCRNXQ1 2026

Institutional Holders
234
13F filers
Shares Held
112.61M
Aggregate institutional
Institutional Value
$3.76B
Q1 2026
Net New Holders
-1
41 new · 42 closed

Institutional Ownership Trend

Aggregate 13F value by quarter

Multi-quarter trend — upgrade to see history

Upgrade

Position Activity

Q1 2026

New positions41
Increased116
Decreased58
Sold out42

Institutional Holders

234 funds hold this security · Q1 2026

#FundSharesValueΔ SharesActivity
1Fmr LLC15.76M$572.40M+1.47MAdded
2Blackrock, Inc.8.48M$307.95M+490.3KAdded
3Farallon Capital Management LLC8.34M$302.84M+8.34MNew
4Wellington Management Group LLP8.16M$296.27M+119.3KAdded
5Driehaus Capital Management LLC6.40M$232.30M+8.2KAdded
6Janus Henderson Group PLC4.52M$164.23M+79.6KAdded
7Ecor1 Capital, LLC4.29M$155.74M0Held
8Bellevue Group AG3.28M$119.13M+3.28MAdded
9Geode Capital Management, LLC2.48M$90.12M+238.1KAdded
10State Street Corp2.40M$87.28M+241.7KAdded

224 more institutional holders on Premium

See every fund holding Crinetics Pharmaceuticals In, with full quarter-over-quarter share changes.

Unlock all holders